| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Neurology, Vol 45, Issue 6 1193-1198, Copyright © 1995 by American Academy of Neurology
ARTICLES |
N De Stefano, PM Matthews, B Ford, A Genge, G Karpati and DL Arnold
Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, PQ, Canada.
We performed a short-term, double-blind, placebo-controlled, crossover trial of sodium dichloroacetate (DCA) therapy in 11 patients affected by various primary mitochondrial disorders. Independent measures of oxidative metabolism (venous blood metabolites, exercise testing, phosphorus magnetic resonance [MR] spectroscopy of muscle, and proton MR spectroscopy of brain) were used in order to monitor metabolic responses to the drug. One week of DCA treatment produced significant decreases (p < 0.05) in blood lactate, pyruvate, and alanine at rest and after bicycle exercise. Proton MR spectra collected from a supraventricular volume of interest in brain of seven of 11 patients also showed significant changes. Brain lactate/creatine ratio decreased by 42% during DCA treatment (p < 0.05). Brain choline/creatine ratio (which is low in patients with myelinopathies) increased by 18% (p < 0.01) after therapy. N-Acetylaspartate/creatine ratio (an index of neuronal damage or loss) increased by 8% after treatment (p < 0.05). Proton MR spectra collected in two of 11 patients from a volume of interest including the basal ganglia showed similar results (decrease of 36.6% in lactate/creatine; increases of 16% in choline/creatine and 4.5% in N-acetylaspartate/creatine). Phosphorus MR spectroscopy of muscle and self-assessed clinical disability were unchanged. Our study indicates that short-term DCA treatment not only lowers blood lactate but also improves indices of both brain oxidative metabolism and neuronal and glial density or function.
This article has been cited by other articles:
|
|
 |
|
  J. O. Heidenreich, T. Klopstock, T. Schirmer, P. Saemann, W. Mueller-Felber, and D. P. Auer Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain. Am. J. Roentgenol., September 1, 2006; 187(3): 820 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kaufmann, K. Engelstad, Y. Wei, S. Jhung, M. C. Sano, D. C. Shungu, W. S. Millar, X. Hong, C. L. Gooch, X. Mao, et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial Neurology, February 14, 2006; 66(3): 324 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Duncan, L. A. Perkins, D. W. Theriaque, R. E. Neiberger, and P. W. Stacpoole Dichloroacetate Therapy Attenuates the Blood Lactate Response to Submaximal Exercise in Patients with Defects in Mitochondrial Energy Metabolism J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1733 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. DIMAURO, M. MANCUSO, and A. NAINI Mitochondrial Encephalomyopathies: Therapeutic Approach Ann. N.Y. Acad. Sci., April 1, 2004; 1011(1): 232 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Bianchi, M. Tosetti, R. Battini, M. L. Manca, M. Mancuso, G. Cioni, R. Canapicchi, and G. Siciliano Proton MR Spectroscopy of Mitochondrial Diseases: Analysis of Brain Metabolic Abnormalities and Their Possible Diagnostic Relevance AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1958 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Cooper and R. Fox Anesthesia for Corrective Spinal Surgery in a Patient with Leigh's Disease Anesth. Analg., November 1, 2003; 97(5): 1539 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Farina, L. Chiapparini, G. Uziel, M. Bugiani, M. Zeviani, and M. Savoiardo MR Findings in Leigh Syndrome with COX Deficiency and SURF-1 Mutations AJNR Am. J. Neuroradiol., August 1, 2002; 23(7): 1095 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Shanske, S. Shanske, and S. DiMauro The Other Human Genome Arch Pediatr Adolesc Med, November 1, 2001; 155(11): 1210 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Clay, M. Behnia, and K. K. Brown Mitochondrial Disease : A Pulmonary and Critical-Care Medicine Perspective Chest, August 1, 2001; 120(2): 634 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. De Stefano, M. T. Dotti, M. Mortilla, and A. Federico Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis Brain, January 1, 2001; 124(1): 121 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Graham, P. B. Barker, W. M. Brooks, D. C. Morris, W. Ahmed, E. Bryniarski, D. O. Hearshen, J. A. Sanders, B. A. Holshouser, and C. C. Turkel MR spectroscopy study of dichloroacetate treatment after ischemic stroke Neurology, November 14, 2000; 55(9): 1376 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. D. Park, J. D. Allison, K. L. Weiss, J. R. Smith, M. R. Lee, and D. W. King Proton Magnetic Resonance Spectroscopic Observations of Epilepsia Partialis Continua in Children J Child Neurol, November 1, 2000; 15(11): 729 - 733. [Abstract] [PDF]
|
|
|
|
|
|
K. J. Morten, P. Beattie, G. K. Brown, and P. M. Matthews Dichloroacetate stabilizes the mutant E1{alpha} subunit in pyruvate dehydrogenase deficiency Neurology, August 1, 1999; 53(3): 612 - 612. [Abstract] [Full Text]
|
|
|
|
|
|
B. G. JENKINS, Y. I. CHEN, E. KUESTERMANN, N. M. MAKRIS, T. V. NGUYEN, E. KRAFT, A. L. BROWNELL, H. D. ROSAS, D. N. KENNEDY, B. R. ROSEN, et al. An Integrated Strategy for Evaluation of Metabolic and Oxidative Defects in Neurodegenerative Illness Using Magnetic Resonance Techniques Ann. N.Y. Acad. Sci., January 1, 1999; 893(1): 214 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Pavlakis, P. B. Kingsley, G. P. Kaplan, P. W. Stacpoole, M. O'Shea, and D. Lustbader Magnetic Resonance Spectroscopy: Use in Monitoring MELAS Treatment Arch Neurol, June 1, 1998; 55(6): 849 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W Stacpoole, C. L Barnes, M. D Hurbanis, S. L Cannon, and D. S Kerr Treatment of congenital lactic acidosis with dichloroacetate Arch. Dis. Child., December 1, 1997; 77(6): 535 - 541. [Full Text]
|
|
|
|
 |
|
 P. F CHINNERY and D. M TURNBULL Clinical features, investigation, and management of patients with defects of mitochondrial DNA J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 559 - 563. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ashwal, B. A. Holshouser, D. B. Hinshaw Jr., R. M. Schell, and L. Bailey PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE EVALUATION OF CHILDREN WITH CONGENITAL HEART DISEASE AND ACUTE CENTRAL NERVOUS SYSTEM INJURY J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 403 - 414. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
